Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023

VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi

见时知几：2023年Fierce15药企预示着哪些投资趋势- 知乎

Proxygen (@ProxygenTx) / X

Mitchell Pease on LinkedIn: #innovation #biotech #lifesciences

Fierce Biotech on LinkedIn: Takeda bets $4B upfront on Nimbus

Proxygen LinkedIn

2023“生物技术猛公司”榜单火热出炉，它们带来了哪些突破? - 知乎

Introducing Fierce Biotech's 2023 Fierce 15

Proxygen LinkedIn

Fierce Biotech on LinkedIn: The Future of Biotech

Mark Federici on LinkedIn: Crossbow Therapeutics Launches with $80

Jacob Perrett posted on LinkedIn

Fierce Life Sciences Events on LinkedIn: The Future of Biotech

Chris Jenkins على LinkedIn: #genetherapy #community

Fierce Biotech on LinkedIn: Treading where Roche and Sanofi failed